Skip to content
Lower risk Drug recall · FDA · Published December 26, 2018

Glenmark Estradiol Vaginal Inserts Recall: Plunger Malfunction Risk

Glenmark Pharmaceuticals recalls Estradiol Vaginal Inserts (10 mcg) due to customer reports of plunger malfunction in applicators. Affected units have specific NDC numbers and batch dates.

🇺🇸 FDA recall #D-0350-2019DrugGlenmark ›
Take action

Contact the company

Recalling firmGlenmark Pharmaceuticals Inc., USA750 Corporate Dr · Mahwah, NJ 07430-2009
✎ GovInfoNow plain-language explainer

Glenmark Pharmaceuticals is recalling Estradiol Vaginal Inserts (10 mcg) because customers report the applicator plunger may malfunction. This could lead to improper hormone delivery if the device doesn't work correctly. Read more at govinfonow.com/recall/39293-glenmark-estradiol-vaginal-inserts-recall-plunger-malfunction-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/39293-glenmark-estradiol-vaginal-inserts-recall-plunger-malfunction-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-0350-2019

Cite this page

“Glenmark Estradiol Vaginal Inserts Recall: Plunger Malfunction Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39293-glenmark-estradiol-vaginal-inserts-recall-plunger-malfunction-risk. Based on FDA recall #D-0350-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0350-2019%22&limit=1).

The FDA announced on 2018-12-26 that Glenmark Pharmaceuticals Inc., USA is recalling Estradiol Vaginal Inserts, USP, 10 mcg due to a defective delivery system. The agency classified the recall as Class II.

How to tell if you have it

  • Brand: Glenmark
  • Product: Estradiol Vaginal Inserts, USP, 10 mcg
  • NDC 68462-711-71 (8 count)
  • NDC 68462-711-88 (18 count)
  • Lot 20180393, exp. 01/31/2020
  • Lot 20180424, exp. 02/29/2020
  • Lot 20180425, exp. 02/29/2020
  • Lot 20180427, exp. 02/29/2020
  • Lot 20180338, exp. 12/31/2019
  • Lot 20180386, exp. 01/31/2020

The hazard

The recall addresses customer complaints regarding a malfunctioning plunger of the applicator. The FDA stated that this defect constitutes the hazard for the recalled product.

Context

GovInfoNow's records show Glenmark Pharmaceuticals Inc., USA has 54 other recalls on record since 2017-11-20. Other recent recalls of similar products include Glenmark Azelaic Acid Gel 15% Recall (2026-07-23), Glenmark Alyacen Birth Control Tablets Recall (2026-05-27), and Glenmark Ondansetron Tablets Recall (2025-12-30). Other recent recalls of similar products include ANI Pharmaceuticals Recalls Estradiol Gel Due to Defective Containers (2026-05-12), Baxter Vasopressin Injection Recall (2026-08-06), and Teva Octreotide Acetate 30mg Kit (2026-04-24).

How to tell if you have this one

Check for cartons labeled 'Estradiol Vaginal Inserts, USP, 10 mcg, Rx only' with NDC numbers 68462-711-71 (8 count) or 68462-711-88 (18 count). Products from batches listed in the description are affected.

  • Brand
    Glenmark
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the NDC numbers 68462-711-71 or 68462-711-88 on the carton.

  2. Contact Your Doctor

    Discuss alternative hormone therapy options with your healthcare provider if you have the recalled product.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Product was distributed to 5 retailers and 4 distributors throughout the United States who may have further distributed the recalled product.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 21 months after the firm started it.

1. Firm started the recall: Dec 26, 201812. FDA classified it Class II: Jan 8, 201923. Published in FDA’s Enforcement Report: Jan 16, 201934. FDA terminated the recall: Oct 6, 2020420182020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Glenmark recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0350-2019 (December 26, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0350-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA